Britain’s Serious Fraud Office has launched a criminal inquiry into GlaxoSmithKline less than two weeks after the drugmaker was accused of “massive and systemic bribery” in China.
The UK group said it had been notified on Tuesday that the SFO had “opened a formal criminal investigation into the group’s commercial practices”. The SFO confirmed the move.
GSK gave no further details but said it would co-operate fully.
您已閱讀25%（416字），剩餘75%（1275字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。